...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: "FYI event tmr!" - from Sarah

sorry about that- i have now posted it on the rv board.

Share
New Message
Please login to post a reply